Ligand Pharma (LGND) Tops Q4 EPS by 49c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $290.07 +2.32%
Revenue Growth %: -32.2%
Financial Fact:
Other, net: 1.22M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: -32.2%
Financial Fact:
Other, net: 1.22M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Ligand Pharma (NASDAQ: LGND) reported Q4 EPS of $1.36, $0.49 better than the analyst estimate of $0.87. Revenue for the quarter came in at $50.38 million versus the consensus estimate of $44.09 million.
For earnings history and earnings-related data on Ligand Pharma (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Ledyard Financial Group adds two directors, three retire
- LEEF Brands appoints Hirsh Jain to board as independent director
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
